Spire Healthcare Group PLC (LON:SPI) has been assigned a consensus rating of “Hold” from the eight analysts that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is GBX 295.57 ($4.08).
A number of brokerages have recently issued reports on SPI. Liberum Capital increased their price target on shares of Spire Healthcare Group from GBX 270 ($3.73) to GBX 275 ($3.80) and gave the company a “hold” rating in a report on Friday, January 26th. JPMorgan Chase & Co. cut their price target on shares of Spire Healthcare Group from GBX 339 ($4.68) to GBX 293 ($4.05) and set a “neutral” rating for the company in a report on Monday. Barclays cut their price target on shares of Spire Healthcare Group from GBX 270 ($3.73) to GBX 255 ($3.52) and set an “equal weight” rating for the company in a report on Monday, March 5th. Numis Securities reiterated an “add” rating and issued a GBX 296 ($4.09) price target on shares of Spire Healthcare Group in a report on Tuesday, January 16th. Finally, Jefferies Group upgraded shares of Spire Healthcare Group to a “buy” rating and increased their price target for the company from GBX 259 ($3.58) to GBX 290 ($4.01) in a report on Wednesday, January 17th.
Shares of Spire Healthcare Group (SPI) traded up GBX 0.60 ($0.01) on Friday, hitting GBX 218 ($3.01). 1,180,000 shares of the stock were exchanged, compared to its average volume of 1,760,000. The stock has a market cap of $874.36 and a P/E ratio of 5,450.00. Spire Healthcare Group has a 1-year low of GBX 206.40 ($2.85) and a 1-year high of GBX 362.10 ($5.00).
Spire Healthcare Group (LON:SPI) last announced its quarterly earnings results on Friday, March 2nd. The company reported GBX 14.40 ($0.20) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of GBX 14.60 ($0.20) by GBX (0.20) ($0.00). The company had revenue of £931.70 million during the quarter. Spire Healthcare Group had a net margin of 1.85% and a return on equity of 1.71%.
The firm also recently disclosed a dividend, which will be paid on Tuesday, June 26th. Investors of record on Thursday, May 31st will be paid a GBX 2.50 ($0.03) dividend. This represents a yield of 1.12%. This is a boost from Spire Healthcare Group’s previous dividend of $1.30. The ex-dividend date of this dividend is Thursday, May 31st.
In other Spire Healthcare Group news, insider Justin Ash acquired 46,500 shares of the stock in a transaction that occurred on Tuesday, March 6th. The shares were purchased at an average cost of GBX 215 ($2.97) per share, with a total value of £99,975 ($138,125.17).
TRADEMARK VIOLATION NOTICE: This news story was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright laws. The legal version of this news story can be read at https://www.dispatchtribunal.com/2018/04/07/spire-healthcare-group-plc-spi-receives-consensus-rating-of-hold-from-analysts.html.
Spire Healthcare Group Company Profile
Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.